🔴 Veraxa Biotech is trading 10.23% down today after likely profit-taking

Veraxa Biotech is trading at $1.58, down 10.23%, as likely profit-taking follows its sharp multi-session advance.

• Shares rose 15.03% to $1.76 on September 4 before retreating.
• Broader U.S. markets are weaker: the Dow Jones is down 1.15%, while the S&P 500 is down 0.50%.
• Veraxa Biotech announced CFO Raju Willener’s appointment on September 8, but the release did not link it to the decline; trading-volume details were unavailable.